Maxiquine tablets are indicated for the treatment of immune system diseases such as Lupus Erythematosus, liver amoebiasis, and Photosensitivity.
The active ingredient is Chloroquine Phosphate B.P. 250mg. Chemically, it is (RS) -7- Chloro-4-(4-diethyl amino-1-methylbutylamino)-quinolin bis (dihydrogen phosphate).
4 tablets daily for 2 days, followed by 1 tablet twice daily for 2 weeks, orally.
Pruritus, visual disturbances, gastrointestinal disturbances, purpura, hepatic damage (including irreversible hepatic necrosis in large doses), dryness of mouth, throat and nose, and abdominal pain with vomiting or diarrhea.
Yes. Severe hypersensitivity to Chloroquine or 4-aminoquinoline compounds, anticholinergics of atropine or opioid analgesics (e.g., morphine), and known allergies to antihistamines or parabens.
Caution in patients with angle-closure glaucoma, urinary retention, pyloroduodenal obstruction, epilepsy, and hepatic or renal impairment. Avoid in patients taking MAOIs or within ten days of discontinuing them.
Below 30°C and protected from light.
It acts as an anti-immune agent by inhibiting the release or activity of cytokines involved in the inflammatory process.
1 tablet twice daily for one week, followed by 1 tablet daily for another week.
Packs of 10 and 1000 tablets.
Vitabiotics (Nig.) Ltd., located at 35, Mobolaji Johnson Avenue, Oregun Industrial Estate, Ikeja, Lagos, Nigeria.
1 tablet daily for two weeks.